ALC

4.69%

6.7¢ alcidion group limited

I’ll be attending the Monday lunchtime Melbourne investor...

First 13 Last

Share
Profile

Follow
Dicebat

425 Posts.

91

22/03/19

22:47

Post #: 37859017
Share

Originally posted by stocking ↑

Attended Kate's presentation today and here are my thoughts for what they are worth:

- Kate was an extremely professional and knowledgeable speaker; it's great to see this kind of experience in a company with a MC that is ALC speaking confidently about successes to date and the opportunity.
- The market is genuine, tangible and here right now; it will only grow.
- ALC is not trying to be everything to everyone; they are solving simple problems for partners and then expanding (see the slide with the whiteboard > dashboard view). They are also happy to partner with 3rd parties to enable new capabilities.
- ALC has 100+ employees; the acq of MKM was a very good play by management, as they have the on the ground practical experience to implement the solution.
- Miya Precision has substantial upside as a product in isolation - it would be good to learn more about the practical feedback from the Palmerston site, I think this would be good investor info for ALC to focus on to better understand the leverage they have once implemented.
- ALC is genuinely only getting started; the opportunity to leverage the AI capability is only the tip of the iceberg, the patient data at scale could make ALC a highly regarded research platform for major medical / pharma players.
- ALC's solutions are sticky; this is not a fly by night engagement with hospitals, but will drive significant recurring revenue growth.
- A large chunk of the top 20 have a vested interest for the longer term (MKM vendors, key management)

I believe ALC has some exciting years ahead, but I also believe it will likely get taken out sooner (say 12-24 months) rather than later by a bigger player as the story gets out and potential realised.

Price wise, this could easily trade on 10x revenue, and at this stage likely 0.14-0.16c range (crude calculation on current MC and $14M revenue realised this year ex pipeline). Being a realist however, I do think there will be a CR at some point given $1.5M in the kitty and a favourable price rise.

Expand

I’ll be attending the Monday lunchtime Melbourne investor presentation. Please let me know if you have any burning questions that haven’t already been addressed.

I’ll post notes afterwards - in the evening as meetings for work all arvo. Cheers from a happy long term holder - haven’t sold a share. Only the beginning...

Dice

ALC Price at posting: 5.6¢ Sentiment: Buy Disclosure: Held
23 Upvote

1 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

AXP

Tambourah chases gold veins and mineralisation extension with drilling

There are more pages in this discussion • 19 more messages in this thread...

First 13 Last

Add ALC (ASX) to my watchlist

(20min delay)
Last 6.7¢		Change 0.003(4.69%)		Mkt cap ! $72.51M

Open	High	Low	Value	Volume
6.5¢	6.8¢	6.4¢	$40.34K	604.6K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	6.5¢

Sellers (Offers)

Price($)	Vol.	No.
6.7¢	95336	2

View Market Depth

No.	Vol.	Price($)
1	256518	0.065
2	539747	0.064
1	200	0.063
1	10000	0.062
2	149000	0.061

Price($)	Vol.	No.
0.066	128118	1
0.068	232449	1
0.069	50000	1
0.070	160606	2
0.071	20177	1

Last trade - 16.10pm 25/11/2024 (20 minute delay)

ALC (ASX) Chart

I’ll be attending the Monday lunchtime Melbourne investor...

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Tambourah chases gold veins and mineralisation extension with drilling

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I’ll be attending the Monday lunchtime Melbourne investor...

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Tambourah chases gold veins and mineralisation extension with drilling

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News